Concomitant WT1 mutations predict poor prognosis in acute myeloid leukemia patients with double mutant CEBPA

Haematologica. 2018 Nov;103(11):e510-e513. doi: 10.3324/haematol.2018.189043. Epub 2018 May 17.

Feng-Ming Tien^{1

2

3}, Hsin-An Hou⁴, Jih-Luh Tang^{1

3}, Yuan-Yeh Kuo⁵, Chien-Yuan Chen¹, Cheng-Hong Tsai^{1

3}, Ming Yao¹, Chien-Ting Lin^{1

3}, Chi-Cheng Li^{1

3}, Shang-Yi Huang¹, Bor-Sheng Ko¹, Szu-Chun Hsu⁶, Shang-Ju Wu¹, Jia-Hau Liu^{1

3}, Sheng Chieh Chou¹, Woei Tsay¹, Mei-Hsuan Tseng¹, Ming-Chih Liu⁷, Chia-Wen Liu⁷, Liang-In Lin⁸, Wen-Chien Chou^{1

6}, Hwei-Fang Tien⁴

¹ Department of Internal Medicine, Division of Hematology, National Taiwan University Hospital.
² Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University.
³ Tai-Cheng Stem Cell Therapy Center, National Taiwan University.
⁴ Department of Internal Medicine, Division of Hematology, National Taiwan University Hospital hsinanhou@ntu.edu.tw hftien@ntu.edu.tw.
⁵ Graduate Institute of Oncology, College of Medicine, National Taiwan University.
⁶ Department of Laboratory Medicine, National Taiwan University Hospital, Taipei, Taiwan.
⁷ Department of Pathology, National Taiwan University Hospital, Taipei, Taiwan.
⁸ Department of Clinical Laboratory Sciences and Medical Biotechnology, College of Medicine, National Taiwan University, Taipei, Taiwan.

No abstract available

Publication types